BIM Share Price

Open 131.25 Change Price %
High 132.50 1 Day 1.00 0.76
Low 131.25 1 Week 1.50 1.15
Close 132.15 1 Month 2.75 2.13
Volume 16055 1 Year 26.65 25.26
52 Week High 143.20
52 Week Low 97.17
BIM Important Levels
Resistance 2 133.31
Resistance 1 132.83
Pivot 131.97
Support 1 131.47
Support 2 130.99
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
CS 23.50 3.21%
CS 23.50 3.21%
More..
EPA France Top Gainers Stocks
ALDV 0.13 62.50%
MLNEO 2.83 20.43%
ALSER 168.90 16.32%
APAM 33.78 15.72%
APAM 33.78 15.72%
MLLOI 3.80 15.15%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
ALFBA 0.75 13.64%
MT 4.53 12.97%
More..
EPA France Top Losers Stocks
ALALO 0.03 -25.00%
ALADO 0.04 -20.00%
MLLEM 0.59 -18.06%
EEM 3.15 -12.50%
ALFRE 1.08 -10.00%
MLZAM 1.25 -8.09%
GRVO 19.40 -7.62%
MALT 344.00 -5.23%
ALMAS 0.76 -5.00%
MED 0.40 -4.76%
More..

BioMerieux SA (EPA: BIM)

BIM Technical Analysis 2
As on 6th Dec 2016 BIM Share Price closed @ 132.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 120.23 & Sell for SHORT-TERM with Stoploss of 133.11 we also expect STOCK to react on Following IMPORTANT LEVELS.
BIM Target for December
1st Target up-side 134.98
2nd Target up-side 137.39
3rd Target up-side 139.8
1st Target down-side 128.12
2nd Target down-side 125.71
3rd Target down-side 123.3
BIM Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.biomerieux.com
BIM Address
BIM
376, chemin de l
Marcy l'Etoile, 69280
France
Phone: 33 4 78 87 20 00
Fax: 33 4 78 87 20 90
Interactive Technical Analysis Chart BioMerieux SA ( BIM EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BioMerieux SA
BIM Business Profile
bioMérieux SA designs, develops, manufactures, and markets in vitro diagnostic systems for clinical and industrial applications. The company’s diagnostic systems consist of reagents and consumables used to conduct biological tests, for use in performing screening, diagnostic assistance, prognosis, and treatment monitoring; instruments, platforms, or autoanalyzers used for automated testing at high or low throughputs; software to process analyses and systems to interpret the biological test results; and related services, such as the installation and maintenance of instruments, user training, or the audit of laboratory workflows. It offers diagnostic systems for clinical applications, including the diagnosis of infectious diseases, comprising HIV, tuberculosis, and respiratory diseases, as well as cardiovascular diseases and targeted cancers based on the analysis of biological samples, such as blood, saliva, and urine; and for industrial applications, including the analysis of microbiological manufacturing, such as food, pharmaceuticals, and cosmetics. The company markets and sells its products through a network of distributors to private-sector analysis laboratories, hospital laboratories, blood banks, and physician office laboratories; food, pharmaceutical, and cosmetics industries; and independent quality-control laboratories. It has operations in Europe, the Middle East, Africa, North America, Asia-Pacific, and Latin America. The company was formerly known as B-D Mérieux and changed its name to bioMérieux SA. The company was founded in 1963 and is headquartered in Marcy l’Etoile, France. bioMérieux SA is a subsidiary of Institut Mérieux.